News/Events

KFI Conducted Feline TASS for Solensia® now Approved by FDA

A year ago, KFI announced the approval of Solensia® to Zoetis by the European Commission. We are now happy to report that this unique treatment for feline osteoarthritic pain, has been approved by CVM. This is the first monoclonal antibody new animal drug approved for...

read more

Coming in January of 2023 – Canine Dental Studies at KFI

KFI staff are in training to run dental studies as per the Veterinary Oral Health Council (VOHC) standards. The VOHC oversees and approves dental products aimed at reducing build-up of plaque and tartar on teeth.  Dr. Andrew Oster DVM, Director of Animal Health at KFI...

read more

KFI Conducted Feline TASS for Solensia® now Approved by FDA

A year ago, KFI announced the approval of Solensia® to Zoetis by the European Commission. We are now happy to report that this unique treatment for feline osteoarthritic pain, has been approved by CVM. This is the first monoclonal antibody new animal drug approved for...

read more

KFI Construction Announcement

KFI is delighted to announce that construction on the new canine and feline housing, enrichment and procedural space has been completed and has passed the OMAFRA licensing inspection required for research facilities in Ontario to operate. The 5,000 sq foot expansion...

read more